Atlas Trials

Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)

Clinical trial NCT02192424 · COMPLETED

Trial details

NCT number
NCT02192424
Sponsor
Mount Sinai Hospital, Canada
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2014-07-01
Primary completion
2020-08-01
Enrollment
109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.